Mr. Trevor Burns reports

CARDIOL THERAPEUTICS TO WEBCAST VIRTUAL ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS ON JUNE 26TH AT 4:30 P.M. EDT

Cardiol Therapeutics Inc.'s virtual annual general and special meeting of shareholders will be webcast on June 26, 2024, at 4:30 p.m. EDT.

Cardiol Therapeutics 2024 AGM

When:  June 26, 2024, at 4:30 p.m. EDT

Where:  Virtual meeting only via live audio webcast

Additional information on the AGM, including details on how to participate and vote, is available on the company's website.

About Cardiol Therapeutics Inc.

Cardiol Therapeutics is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The company's lead small molecule drug candidate, Cardiolrx (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis and heart failure.

We seek Safe Harbor.